Acadian Asset Management LLC Genocea Biosciences, Inc. Transaction History

Acadian Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.96 - $1.35 $20,871 - $29,350	-21,741 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$0.95 - $1.99 $20,653 - $43,264	21,741 New	21,741 $25,000
Q2 2020 Aug 12, 2020	SELL	$1.66 - $3.06 $18,057 - $33,286	-10,878 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$1.26 - $2.73 $13,706 - $29,696	10,878 New	10,878 $19,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.